India to Australia: Ezetimibe Export Trade Route

The India to Australia Ezetimibe corridor is one of India's established pharmaceutical export routes, with 179 shipments documented worth a combined $6.8M USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 37% of all export value, reflecting the consolidated nature of India's ezetimibe manufacturing sector.

Across 10 active suppliers, the average shipment value stands at $38.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during July–September, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 19.1%, placing it at rank #1 among India's top ezetimibe export destinations globally.

On the import side, key buyers of Indian ezetimibe in Australia include APOTEX PTY LIMITED, ARROW PHARMACEUTICALS PTY LTD, PHARMACOR PTY LTD.,. and 25 others. APOTEX PTY LIMITED is the single largest importer with 23 shipments valued at $1.3M USD.

India's ezetimibe exports to Australia are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 75 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 10 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, TORRENT PHARMACEUTICALS LTD, ALKEM LABORATORIES LIMITED — together account for 73% of total trade value on this route. The average shipment value of $38.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharmaceutical products pharmacor ezetimibe tab 10 mg 3x10's au and others : apo-ezetimibe/simvastatin 10/80 , suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, APOTEX PTY LIMITED is the largest importer with 23 shipments worth $1.3M USD — representing 19% of all ezetimibe imports from India on this route. A total of 28 buyers are active on this corridor.